TuesdayJun 12, 2018 12:39 pm

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF) Announces Launch into Beverage Industry

Strategic planning based off of 125 years of combined experience in the beverage industry Significant expected growth in the beverage and cannabis industry as the two join forces Multi-phase product to create a distribution platform for domestic and international markets Creating a sustainable and successful future that provides quality product worldwide The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), a company that produces farm-grown, high quality organic medical cannabis using organic craft growing principles, has announced a global strategic launch into the beverage industry.  The company’s senior management has over 125 years of combined experience in the beverage…

Continue Reading

TuesdayJun 12, 2018 12:09 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Secures California Extraction Deal as New Ontario Clinic Opens

Sunniva’s Sun-Oil Facility in California will provide Farmacy Phactory with distilled oil products Extraction deal is a significant milestone for the company, cements its position as a reliable manufacturer of clean extracted products New clinic opened in Windsor, Ontario, via wholly owned subsidiary Natural Health Services Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF), a vertically integrated medical cannabis provider, has struck an extraction deal with Farmacy Phactory, a family-run California cannabis farm (http://cnw.fm/uJ63k). Through wholly owned subsidiary CP Logistics, LLC, Sunniva’s Sun-Oil Facility will provide high quality, pure manufactured distilled oil products, including flavored oil formulations for vaporization cartridges. Sunniva will also…

Continue Reading

MondayJun 11, 2018 1:02 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Set to Capitalize on Growth of Dietary Supplement, Drug Delivery Markets

Two separate market research reports predict 7.0 percent and 2.9 percent CAGR, respectively, in PreveCeutical’s areas of operation PreveCeutical developing Sol-Gel, an innovative medicine delivery platform Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is uniquely positioned to capitalize of the growth of two different markets in which it currently operates: dietary supplements and drug delivery systems. Two separate market research reports indicated recently that these sectors are expected to grow a projected 7.0 percent and 2.9 percent, respectively, over the next five years. In a report published in May, Technavio estimated that the global dietary…

Continue Reading

MondayJun 11, 2018 12:21 pm

Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) Reaffirms Expectations with Confirmation of Readiness from Health Canada

Sunniva confirms analyst expectations with COR from Health Canada Company and announcement featured in Seeking Alpha article Over one million square feet of cannabis cultivation facilities under construction Grow facilities in California and Canada target 60 million adults Biopharmaceutical company Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) now seems set for a place in the sun. The North American provider of cannabis products and services announced on May 29, 2018, that its wholly owned subsidiary, Sunniva Medical Inc. (“SMI”), had received a Confirmation of Readiness (COR) notification from Health Canada. The good news has not gone unnoticed, with one analyst remarking,…

Continue Reading

MondayJun 11, 2018 11:51 am

Xanthic Biopharma, Inc. (CSE: XTHC) Pursues Profitability in 2019 by Expanding Marketing of Cannabinoid-Infused Powders via Strategic Partners

xTHC produces cannabinoid-infused drink powders from a non-cannabis and non-hemp source using a patent-pending process Business model is to be a first-mover and expand into more U.S. states, with the focus now on the California market; goal is to reach broad-based retail channels, not only dispensaries Company is partnering with and is minority owner of Oregon-based Avitas CBD Water, LLC (now renamed Xanthic Beverages) Xanthic Biopharma, Inc. (CSE: XTHC), on its initial investor conference call, projected multi-million dollar revenue and profitability in 2019 as it grows. It is a manufacturer of CBD-infused drink powder from a non-cannabis and non-hemp, economically…

Continue Reading

FridayJun 08, 2018 1:43 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) and the US Senate Celebrate Hemp History Week

U.S. Senate declares ‘Hemp History Week’ from June 4-10 Pending legislation in U.S. Congress to remove restrictions on hemp cultivation Hemp cultivation operations underway in the U.S. and Canada for Global Hemp Group Forty-eight years after the Controlled Substances Act (CSA) of 1970 criminalized its use, hemp may finally be escaping from its stigma as an illegal substance. An omen of that impending legitimacy appeared on Tuesday, June 5, 2018, when the U.S. Senate approved a resolution declaring June 4-10 ‘Hemp History Week’. The resolution made note of "the growing economic potential of industrial hemp" as well as its "historical relevance," and…

Continue Reading

TuesdayJun 05, 2018 11:30 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expands Patent Portfolio, Announces Exercise of 450,000 Existing Warrants

LXRP, a drug delivery platform innovator, has been awarded two new patent grants in the U.S. and expects three more from Australia Company already has more than 40 patent awards or applications from 40 countries globally; it is preparing new patent application filings and predicts more patent awards this year LXRP received $63,000 from the exercise of 450,000 warrants previously granted to third parties Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is growing its patent portfolio with two more patent grants in the U.S., predicting three more from Australia, and it is currently preparing new patent application filings as it…

Continue Reading

MondayJun 04, 2018 2:23 pm

BLOCKStrain Technology Corp. (TSX.V: DNAX) Leverages Big Data to Secure Cannabis Pipeline

Blockchain-based genetic registration process provides verification security for growers and consumers alike Global cannabis market projected to reach $31.4 billion by 2021 WeedMD becomes first Canadian Licensed Producer to adopt BLOCKStrain’s technology As the legal cannabis market continues to develop, concerns about ensuring transparency and quality control for the growing number of medicinal and recreational drug products sold to consumers continue to drive a necessary breed of entrepreneurship required to legitimize the industry. BLOCKStrain Technology Corp. (TSX.V: DNAX) has emerged as an innovative leader in the quality control arena, releasing its proprietary supply chain management platform as a secure means…

Continue Reading

ThursdayMay 31, 2018 11:43 am

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Places Bet in Oregon as CBD Goes Up and THC Goes Down

Cannabis cultivation plagued by legal peril and price volatility Demand for non-psychotropic cannabinoids is growing rapidly GHG hemp cultivation projects now underway in the U.S. and Canada In California, Oregon, and Washington State, cannabis farmers (growing mainly for THC content) are now suffering from the unwelcome truth in economics – prices of almost everything seesaw perennially. In the case of cannabis, wholesale prices have entered a freefall, motivating farmers to cultivate hemp for CBD extraction in place of cannabis. As a result, Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) and Marijuana Company of America (OTC: MCOA) are…

Continue Reading

TuesdayMay 29, 2018 1:26 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Adding Value to Nature-Identical Therapies Portfolio

Stock split, CSE listing show evidence of company’s shareholder commitment PreveCeutical balancing need for unique profit-building intellectual property with mission to offer affordable products to patients Manufacturer agreement, licensed shipments advance CBD therapy research Alternative medicines market valued at more than $40 billion PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) dedication to developing preventative medical therapies based on the identified health benefits of natural substances in controllable formulations that are both affordable to consumers and potentially profitable to investors is on display in the company’s recent shareholder-approved forward stock split and the opening of trade on the Canadian…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000